News

News

[Job Opening] Business Development Manager – Boston office

[채용 공고]유한양행 미국 법인 - 유한 USA Position:Business Development Manager Work location:Boston, MA Responsibilities:1.개방형 기술혁신 및 In/Out Licensing Partnering 사업개발2.유망 바이오 기업 발굴 및 전략적 투자활동3.신약개발 연구 및 바이오 파마 ...
Read More

Yuhan Corporation to create a state-of-the-art R&D cluster in Gunpo-City, South Korea

Yuhan Corporation is working together with Gunpo City, South Korea to create a high-tech bio research base and CMC center in the industrial area of Dangjeong-dong, Gunpo. Yuhan Corporation will ...
Read More

Yuhan Corporation’s licensed-out non-alcoholic steatohepatitis drug to start phase 1 clinical trial in Europe

Expected to receive 10 million USD as a milestone payment Yuhan Corporation (000100. KS) announced on the 17th of November that the new drug candidate (YH25724) for the treatment of ...
Read More

Yuhan Corporation to invest 1.6 billion Won (1.34 million USD) in Yuhan USA U.S. Open Innovation Investment Continues

Yuhan USA strengthens its role as a 'venture capital'. They purchased 750,000 shares of Processa Pharmaceuticals this year. Yuhan Corporation is spurring overseas open innovation expansion and strengthening its global ...
Read More

Processa Pharmaceuticals’ PCS12852, originally developed by Yuhan Corp, cleared by FDA to Proceed with Ph2a Trial for Gastroparesis

Processa Pharmaceuticals announced that they have been cleared by the FDA to proceed with a Phase 2a clinical trial of PCS12852 in patients with moderate to severe gastroparesis. PCS12852 is ...
Read More

[Job Opening] Associate, Business Operations – San Diego office

Job description Responsibilities: Provide administrative support to include arranging travel plans and meetings; interact and liaise with members of the functional team, management and external clientsPerform office duties that include ...
Read More

Yuhan Corporation – Introduction Video

Learn more about our parent company “Yuhan Corporation by watching this video ...
Read More

Yuhan to license out a gastrointestinal drug candidate to Processa for $415 million

Yuhan Corporation entered into a licensing agreement worth up to $415 million with Processa Pharmaceuticals for the development of YH12852, a small molecule drug in development for the treatment of ...
Read More

[Job Opening] Business Development Manager – San Diego office

Yuhan USA Corporation was established in January 2018 as a wholly-owned subsidiary of Yuhan Corporation, Korea’s largest pharmaceutical company with a 94-year heritage. As an outpost of Yuhan’s globalization strategy, ...
Read More

Yuhan-AbClon now in the race for a COVID-19 therapeutic antibody

Yuhan and AbClon have joined the list of pharmaceutical companies that are in the race to develop a therapeutic antibody for COVID-19. They have identified a multifariously adaptive candidate for ...
Read More